M. K. Shah, M. A. Shah, and S. D. Shah, “Risk of hypertension with bevacizumab, an antibody against vascular endothelial growth factor A: a systematic review and meta-analysis”, Int J Basic Clin Pharmacol, vol. 8, no. 10, pp. 2354–2360, Sep. 2019.